2021
Safety Evaluation of the Second Dose of Messenger RNA COVID-19 Vaccines in Patients With Immediate Reactions to the First Dose
Krantz MS, Kwah JH, Stone CA, Phillips EJ, Ortega G, Banerji A, Blumenthal KG. Safety Evaluation of the Second Dose of Messenger RNA COVID-19 Vaccines in Patients With Immediate Reactions to the First Dose. JAMA Internal Medicine 2021, 181: 1530-1533. PMID: 34309623, PMCID: PMC8314170, DOI: 10.1001/jamainternmed.2021.3779.Peer-Reviewed Original Research
2019
Addressing Comorbidities in Difficult Asthma
Kwah J, Peters A, Khatri S. Addressing Comorbidities in Difficult Asthma. Respiratory Medicine 2019, 55-74. DOI: 10.1007/978-3-030-20812-7_4.Peer-Reviewed Original ResearchTreat asthmaAsthma controlAspirin-exacerbated respiratory diseaseChronic oral corticosteroidsPoor asthma controlVocal cord dysfunctionObstructive sleep apneaLaryngopharyngeal reflux diseaseManagement of patientsSignificant symptomatic reliefOral corticosteroidsDifficult asthmaReflux diseaseAllergic rhinitisChronic rhinosinusitisCord dysfunctionSymptomatic reliefComorbid conditionsSleep apneaNasal polypsRespiratory diseaseAsthmaCorticosteroidsPatientsDiseaseRespiratory Virus Detection in Nasal Lavage Fluid of Chronic Rhinosinusitis Patients During Acute Exacerbations
Kwah J, Benjamin M, Fischer S, Biyasheva A, Hadzic A, Kato A, Stevens W, Kern R, Smith S, Avila P, Welch K, Conley D, Tan B, Grammer L, Schleimer R, Peters A. Respiratory Virus Detection in Nasal Lavage Fluid of Chronic Rhinosinusitis Patients During Acute Exacerbations. Journal Of Allergy And Clinical Immunology 2019, 143: ab86. PMCID: PMC7133156, DOI: 10.1016/j.jaci.2018.12.266.Peer-Reviewed Original Research